Interaction of cyclosporine and probucol in heart transplant patients
Sundararajan, V.; Cooper, D.K.; Muchmore, J.; Manion, C.V.; Liguori, C.; Zuhdi, N.; Novitzky, D.; Chen, P.N.; Bourne, D.W.; Corder, C.N.
Transplantation Proceedings 23(3): 2028-2032
1991
ISSN/ISBN: 0041-1345 PMID: 2063476 Document Number: 376037
Document emailed within 1 workday
Related Documents
Andert, S.E.; Feichtinger, E.; Grabenwöger, M.; Grimm, M.; Schreiner, W.; Müller, M.M. 1993: Cyclosporine a increases angiotensin-converting enzyme activity in heart transplant patients Transplantation Proceedings 25(4): 2735-2737Keren, A.; Gillis, A.M.; Freedman, R.A.; Baldwin, J.C.; Billingham, M.E.; Stinson, E.B.; Simson, M.B.; Mason, J.W. 1984: Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine Circulation 70(3 Part 2): I124-I129
Jazzar, A.; Fagiuoli, S.; Sisson, S.; Zuhdi, N.; Cooper, D.K. 1994: Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients Transplantation Proceedings 26(5): 2749
Smith, C.L.; Hampton, E.M.; Pederson, J.A.; Pennington, L.R.; Bourne, D.W. 1994: Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients PharmacoTherapy 14(4): 471-481
Trull, A.; Hue, K.; Tan, K.; Gore, S.; Whitewood, S.; Smyth, R.; Scott, J.; Price, C.; Wallwork, J. 1990: Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients Clinical Chemistry 36(8 Part 1): 1474-1478
Chomette, G.; Auriol, M.; Beaufils, H.; Rottemburg, J.; Cabrol, C. 1986: Morphology of cyclosporine nephrotoxicity in human heart transplant recipients Journal of Heart Transplantation 5(4): 273-278
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Lloveras, J.J.; Durand, D.; Ader, J.L.; Tran Van, T.; Rostaing, L.; Cerene, A.; Fournial, G.; Suc, J.M. 1993: Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period Transplantation Proceedings 25(3): 2226
Militerno, G.; Gugenheim, J.; Cuomo, O.; Hofman, P.; Mouiel, J.; Tovey, M. 1994: Synergistic interaction between anti-IFN alpha/beta antibody and low doses of cyclosporine therapy prolongs heart transplants in rats Transplantation Proceedings 26(5): 3050-3051
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
McCauley, J.; Fung, J.J.; Brown, H.; Deballi, P.; Jain, A.; Todo, S.; Starzl, T.E. 1991: Renal function after conversion from cyclosporine to FK 506 in liver transplant patients Transplantation Proceedings 23(6): 3148-3149
Schulz, A.; Lange, D.E.; Hassell, T.M.; Stone, C.E.; Lison, A.E. 1990: Cyclosporine-induced gingival hyperplasia in renal transplant patients Deutsche Zahnarztliche Zeitschrift 45(7): 414-416
Cheymol, G. 1993: Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant patients Annales de Gastroenterologie et d'Hepatologie 29(2): 81-85
Takahashi, K.; Yagisawa, T.; Teraoka, S.; Toma, H.; Agishi, T.; Ota, K.; Kobayashi, S. 1987: Viral infections in kidney transplant patients immunosuppressed with cyclosporine Transplantation Proceedings 19(1 Part 3): 2142-2149
Kliem, V.; Wanner, C.; Eisenhauer, T.; Olbricht, C.J.; Doll, R.; Boddaert, M.; O'Grady, P.; Krekler, M.; Mangold, B.; Christians, U. 1996: Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine Transplantation Proceedings 28(6): 3126-3128
Massari, P.U.; Garay, G.; Ulla, M.R. 1994: Bone mineral content in cyclosporine-treated renal transplant patients Transplantation Proceedings 26(5): 2646-2648
Awni, W.M.; Kasiske, B.; Heim-Duthoy, K.; Rose, M.; Rao, V.K.; Bloom, P.; Ney, A.; Andrisevic, J.; Odland, M.; Andersen, R.C. 1988: Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period Transplantation Proceedings 20(2 Suppl. 2): 623-624
Marcen, R.; Serrano, P.; Teruel, J.L.; Rivera, M.E.; Mitjavila, M.; Navarro, J.; Orofino, L.; Sabater, J.; Ortuño, J. 1994: Oral cimetidine improves the accuracy of creatinine clearance in transplant patients on cyclosporine Transplantation Proceedings 26(5): 2624-2625